These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-004577-23 Remifentanil as pain relief during labour not-yet-due
Ongoing 2005-005111-24 Fluid therapy to patients reciving therapeutic hypothermia after cardiac arrest not-yet-due
Ongoing 2006-002832-10 Liitännäishoitona annetun oksaliplatiinipohjaisen solusalpaajahoidon jälkeinen hedelmällisyys kolorektaalisyöpäpotilailla. Pohjoismainen prospektiivinen tutkimus. Fertility in colorectal cancer patien... not-yet-due
No trial status on register 2006-006469-17 A multicenter study to investigate the Sensitivity and Specificity of Aridol (Mannitol)Challenge as compared with Methacholine Challenge to predict a diagnosis of Asthma by a Specialist Pulmonologist ... bad-data
Ongoing 2006-006616-30 Behandling med hyperton-kolloidal infusjon ved hjertekirurgi not-yet-due
Not reported 2009-010917-61 Glucocorticoid Replacement in Addison's disease 2012-12-06 due-trials
Ongoing 2009-013094-17 A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral lenalidomide to standard induction therapy in AML and RAEB ≥ 66 years and v... not-yet-due
Ongoing 2009-014455-68 A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral tosedostat to standard induction therapy in AML and RAEB ≥ 66 years and ver... not-yet-due
Ongoing 2010-022307-22 The Bergen Psychosis Project 2 not-yet-due
Ongoing 2010-023740-32 Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder not-yet-due
Exempt 2010-024289-24 TREATMENT OF PANCREATIC ADENOCARCINOMA BY COMBINING CONTRAST AGENT AND GEMCITABINE UNDER SONICATION not-yet-due
Ongoing 2011-002689-19 TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: DISEASE STABILIZATION THROUGH CHEMOTHERAPY, IMMUNOMODULATORY TREATMENT AND IMMUNOTHERAPY not-yet-due
Listed as ongoing, but also has a completion date 2011-005822-23 CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA 2017-02-20 bad-data
Ongoing 2012-000323-41 Randomised Trial of Contrast-enhanced Sonothrombolysis in acute ischaemic stroke not-yet-due
Ongoing 2012-001020-35 A randomized phase II trial comparing bevacizumab monotherapy with dacarbazine (DTIC) in treatment of malignant melanoma, focusing on angiogenic markers and prevention of hypertension. not-yet-due
Ongoing 2012-001175-36 LOW-DOSE KETAMINE AS ADJUVANT TREATMENT TO MORPHINE IN NEUROPATHIC CANCER PAIN. not-yet-due
Ongoing 2012-003139-50 International, multicenter phase II uncontrolled prospective clinical trial: not-yet-due
Ongoing 2013-002524-16 Everolimus and temozolomide as first-line treatment in advanced gastrointestinal neuroendocrine carcinoma (G3) with a Ki67 of 20-55% not-yet-due
Ongoing 2013-004189-33 ULTRADIAN SUBCUTANEOUS HYDROCORTISONE (USHI) INFUSION IN ADDISON’S DISEASE not-yet-due
Exempt 2014-000302-34 Ipratropium bromide ved anstrengelsesutløst laryngeal obstruksjon (EILO - Exercise Induced Laryngeal Obstruction). not-yet-due
Ongoing 2014-004029-41 Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. not-yet-due
Ongoing 2016-003459-31 Treatment of patients with advanced breast cancer harboring TP53 mutations with dose-dense cyclophosphamide - the p53 trial not-yet-due
Ongoing 2017-001362-25 Randomized autologous hematopoietic stem cell transplantation versus alemtuzumab for patients with relapsing remitting Multiple Sclerosis not-yet-due
Ongoing 2018-003090-95 The Norwegian Tenecteplase Stroke Trial 2 ( NOR-TEST 2 ) not-yet-due